Last reviewed · How we verify
NCT07425379
Prehabilitation in Breast Cancer Surgery
NA trial testing Home-Based Prehabilitation Exercise Program in Breast Cancer (Early Breast Cancer) in 54 participants. Not yet recruiting.
1 December 2026
Quick facts
| Lead sponsor | Bakirkoy Dr. Sadi Konuk Research and Training Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 54 |
| Start date | 1 March 2026 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2028 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Home-Based Prehabilitation Exercise Program
- Usual Care
Conditions studied
- Breast Cancer (Early Breast Cancer) — all drugs for Breast Cancer (Early Breast Cancer) →
- Postoperative Shoulder Dysfunction — all drugs for Postoperative Shoulder Dysfunction →
- Lymphedema Arm — all drugs for Lymphedema Arm →
- Cancer Rehabilitation — all drugs for Cancer Rehabilitation →
Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Who can join
Adults 18 to 80, female only, with Breast Cancer (Early Breast Cancer) or Postoperative Shoulder Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, randomized, assessor-blinded, parallel-group clinical trial evaluates the effectiveness of a home-based upper extremity-focused prehabilitation program in women undergoing breast cancer surgery. Participants will be randomized 1:1 to either prehabilitation or usual care. Primary outcomes include shoulder range of motion and upper extremity function (DASH score). Secondary outcomes include grip strength, pain, fatigue, disability, anxiety/depression, and lymphedema incidence up to 2 years postoperatively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07425379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer (Early Breast Cancer)
Currently open trials in the same condition.
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07071402 — A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surg · NA · recruiting
Other Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials
Trials by the same sponsor.
- NCT07367321 — Comparison of Onlay Mesh Repair and Sublay Mesh Repair in Umbilical Hernia Surgery · NA · not yet recruiting
- NCT07077629 — Geriatric Patients Undergoing Gynaecological Cancer Surgery · completed
- NCT07000461 — Transcranial Doppler as a Predictor of Postoperative Cognitive Dysfunction Following Cardiopulmonary Bypass · recruiting
- NCT07295405 — Water Temperature and Bowel Cleansing Quality · completed
- NCT07367373 — Impact of the Four Seasons on Bowel Cleansing Quality Prior to Colonoscopy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07425379 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07425379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing